Aarey Drugs & Pharmaceuticals Limited (NSE:AAREYDRUGS)

NSE:AAREYDRUGS Revenue

In the fiscal year ending March 31, 2026, Aarey Drugs & Pharmaceuticals had annual revenue of 4.72B INR, down -0.35%. Aarey Drugs & Pharmaceuticals had revenue of 1.89B in the quarter ending March 31, 2026, with 75.28% growth.

• Revenue: 4.72B
• Revenue Growth: -0.35%
• P/S Ratio: 0.50
• Revenue / Employee: 35.78M
• Employees: 132
• Market Cap: 2.37B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	4.72B	-16.74M	-0.35%
Mar 31, 2025	4.74B	713.61M	17.73%
Mar 31, 2024	4.03B	-163.73M	-3.91%
Mar 31, 2023	4.19B	-739.78M	-15.01%
Mar 31, 2022	4.93B	1.42B	40.27%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 20, 2026

Data Sources Report a data error